Last Updated: June 17, 2026

Details for New Drug Application (NDA): 020165

✉ Email this page to a colleague

NDA 020165 describes NICODERM CQ, which is a drug marketed by Chattem Sanofi and is included in one NDA. It is available from three suppliers. Additional details are available on the NICODERM CQ profile page.

The generic ingredient in NICODERM CQ is nicotine. There are thirty drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the nicotine profile page.

Summary for 020165

Tradename:	NICODERM CQ
Applicant:	Chattem Sanofi
Ingredient:	nicotine
Patents:	0

Pharmacology for NDA: 020165

Medical Subject Heading (MeSH) Categories for 020165

Ganglionic Stimulants
Nicotinic Agonists

Suppliers and Packaging for NDA: 020165

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
NICODERM CQ	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	020165	NDA	Haleon US Holdings LLC	0135-0194	0135-0194-01	7 PATCH in 1 CARTON (0135-0194-01) / 24 h in 1 PATCH
NICODERM CQ	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	020165	NDA	Haleon US Holdings LLC	0135-0194	0135-0194-02	14 PATCH in 1 CARTON (0135-0194-02) / 24 h in 1 PATCH

Profile for product number 004

Active Rx/OTC/Discontinued:	OTC	Dosage:	FILM, EXTENDED RELEASE;TRANSDERMAL			Strength	21MG/24HR
Approval Date:	Aug 2, 1996	TE:		RLD:	Yes

Profile for product number 005

Active Rx/OTC/Discontinued:	OTC	Dosage:	FILM, EXTENDED RELEASE;TRANSDERMAL			Strength	14MG/24HR
Approval Date:	Aug 2, 1996	TE:		RLD:	Yes

Profile for product number 006

Active Rx/OTC/Discontinued:	OTC	Dosage:	FILM, EXTENDED RELEASE;TRANSDERMAL			Strength	7MG/24HR
Approval Date:	Aug 2, 1996	TE:		RLD:	Yes

Expired US Patents for NDA 020165

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chattem Sanofi	NICODERM CQ	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	020165-006	Aug 2, 1996	5,364,630	⤷ Start Trial
Chattem Sanofi	NICODERM CQ	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	020165-005	Aug 2, 1996	8,663,680	⤷ Start Trial
Chattem Sanofi	NICODERM CQ	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	020165-005	Aug 2, 1996	8,075,911	⤷ Start Trial
Chattem Sanofi	NICODERM CQ	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	020165-005	Aug 2, 1996	8,999,379	⤷ Start Trial
Chattem Sanofi	NICODERM CQ	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	020165-005	Aug 2, 1996	5,344,656	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.